BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Will FDA’s Scrutiny of Pfizer’s Chantix Trial Go Up in Smoke?

  September 13, 2016

   · 

  2 min read
• Drug Development

  Despite Trial Deaths, Juno Could Still Be the CAR-T Leader

  September 13, 2016

   · 

  1 min read
• 

  Business

  How Arizona Republicans Also Fell Head-Over-Heels for Theranos’s Elizabeth Holmes

  September 13, 2016

   · 

  2 min read
• 

  Lone Star Bio

  Everything’s Bigger in Texas: Aeglea Quickly Growing into Leading Austin Biotech

  September 13, 2016

   · 

  4 min read
• 

  Business

  Let’s Hear It for the Yale Professor Who Launched New Biotech Kleo

  September 13, 2016

   · 

  2 min read
• 

  Biotech Beach

  Good or Bad? Pharma Bro Thinks Jazz Pharma Could be Worth $20 Billion, Calls Mast Therapeutics ‘Worthless’

  September 13, 2016

   · 

  2 min read
• 

  Biotech Bay

  2 Bargain Pharma Stocks to Snag No Matter Who is Elected

  September 13, 2016

   · 

  2 min read
• Biotech Bay

  How Medivation and This Little Biotech Turned $8,000 Into $250,000+ for Investors

  September 13, 2016

   · 

  1 min read
• 

  Pharm Country

  BOO! Big Pharmas Like GlaxoSmithKline, Pfizer and Mylan Use Scare Tactics to Drum Up Sales

  September 13, 2016

   · 

  2 min read
• Bio NC

  5 Biotech Stocks That Brokers LOVE LOVE LOVE

  September 13, 2016

   · 

  1 min read